Hillstream BioPharma Inc. (HILS)
NASDAQ: HILS
· Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM
Hillstream BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.61M | -8.92M | -8.22M | -8.47M | -4.25M | -2.98M | -2.9M | -2.21M | -5.96M | -5.52M | -3.96M |
Depreciation & Amortization | 1.57B | 1.57B | 1.57B | 1.57B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 863.42K | 946.22K | 1.13M | 800.7K | 605.44K | 369.11K | 584.57K | 1.24M | 1.45M | 1.45M | 896.9K |
Other Working Capital | 1.06M | 634.45K | 107.29K | -427.94K | -516.4K | -554.48K | -333.75K | 196.92K | 143.43K | 183.39K | 288.49K |
Other Non-Cash Items | -1.57B | -1.57B | -1.57B | -1.57B | -932.33K | -664.79K | -245.45K | -1.17M | 1.96M | 1.75M | 1.33M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 535.34K | 93.5K | -938.12K | -569.11K | -921.25K | -717.92K | -40.86K | 1.05M | 949.87K | 917.11K | 603.79K |
Operating Cash Flow | -6.95M | -7.86M | -8.02M | -6.56M | -5.5M | -3.99M | -2.6M | -1.09M | -1.6M | -1.39M | -1.12M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -7.82K | -7.82K | -7.82K | -7.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.04M | 2.28M | 463.14K | 13.06M | 13.05M | 13.45M | 13.7M | 898.75K | 1.59M | 1.41M | 1.14M |
Financial Cash Flow | 2.04M | 2.28M | 463.14K | 13.06M | 13.05M | 13.45M | 13.7M | 898.75K | 1.59M | 1.41M | 1.14M |
Net Cash Flow | -4.91M | -5.58M | -7.55M | 6.51M | 7.55M | 9.45M | 11.1M | -187.5K | -10.57K | 19.94K | 13.18K |
Free Cash Flow | -6.95M | -7.86M | -8.02M | -6.56M | -5.5M | -3.99M | -2.6M | -1.09M | -1.6M | -1.39M | -1.12M |